CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Príomhchruthaitheoir: | Eva, Israt Ara Jannat |
---|---|
Rannpháirtithe: | Rahman, Kazi Fatema |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2023
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/17764 |
Míreanna comhchosúla
-
A review on CRISPR-Cas system based applications in Oncology
de réir: Sadia, Mir
Foilsithe / Cruthaithe: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
de réir: Maria, Amatul
Foilsithe / Cruthaithe: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
de réir: Nwabunwanne, Eze Uchenna
Foilsithe / Cruthaithe: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
de réir: Shaikat, Mahdi Mubin
Foilsithe / Cruthaithe: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
de réir: Ullah, Mohammad
Foilsithe / Cruthaithe: (2023)